Long-Term Apply of Common Acid Reflux Medications May Increase Risk of Anemia and Bone Loss
Millions worldwide rely on proton pump inhibitors (PPIs) to manage conditions like acid reflux, gastritis, and ulcers. These medications, including widely used drugs such as omeprazole (Prilosec), pantoprazole (Protonix), and esomeprazole (Nexium), effectively reduce stomach acid production. However, growing evidence suggests that prolonged use of PPIs may come with significant, and often overlooked, health risks, including impaired nutrient absorption leading to anemia and potential bone density loss. While these medications remain vital for many, a careful assessment of their long-term use and potential alternatives is increasingly warranted.
The concern isn’t with the medications’ efficacy in treating their intended conditions, but rather with their extended, and sometimes unnecessary, use. Stomach acid isn’t solely responsible for discomfort. it plays a crucial role in the body’s ability to absorb essential vitamins and minerals. Disrupting this process over months or years can lead to deficiencies that manifest as serious health problems. Recent research, including studies conducted at the Federal University of São Paulo (UNIFESP) and the ABC Medical School (FMABC) in Brazil, is shedding light on the specific mineral imbalances associated with PPI use, prompting a re-evaluation of prescribing practices and patient self-medication.
The potential for nutrient deficiencies isn’t a new concern, but the scope of the impact is becoming clearer. Beyond iron and calcium, which are directly linked to anemia and osteoporosis respectively, PPIs can also interfere with the absorption of zinc, magnesium, copper, and potassium – all vital for numerous bodily functions. Understanding these complex interactions is crucial for both healthcare providers and individuals managing chronic acid-related conditions. The increasing availability of over-the-counter PPIs, as seen with recent regulatory changes in Brazil, further underscores the need for greater public awareness and responsible medication use.
Mineral Imbalances Observed in Research
Researchers at UNIFESP and FMABC investigated the effects of prolonged omeprazole use on mineral distribution in rats, providing insights into potential consequences for humans. Their findings, published in the journal ACS Omega, revealed significant shifts in mineral levels following 10, 30, and 60-day treatment periods. The study, funded by the São Paulo Research Foundation (FAPESP), demonstrated that omeprazole caused certain minerals to accumulate in the stomach while simultaneously depleting them in the liver and spleen. ACS Omega study
Specifically, blood tests showed elevated calcium levels and reduced iron levels in the treated animals. Elevated calcium, while seemingly benign, can indicate an imbalance in calcium regulation, potentially leading to calcium being drawn from bones, increasing the risk of osteoporosis over time. Lower iron levels directly contribute to iron-deficiency anemia, characterized by fatigue, weakness, and impaired cognitive function. The researchers also noted alterations in immune system cells, suggesting a broader impact of PPI-induced mineral imbalances on overall health. Angerson Nogueira do Nascimento, a professor at UNIFESP who coordinated the study, emphasized the need for longer-term studies to confirm the link between elevated calcium and osteoporosis risk, but the initial findings are concerning.
How Proton Pump Inhibitors Work and Why They Affect Nutrient Absorption
Proton pump inhibitors work by blocking the H+, K+, ATPase enzyme, commonly known as the proton pump. This enzyme is essential for the final step in producing hydrochloric acid in the stomach. By inhibiting this enzyme, PPIs effectively reduce acid production, alleviating symptoms of ulcers, gastritis, and gastroesophageal reflux disease (GERD). National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) on GERD
However, stomach acid isn’t just about digestion; it’s a critical component of nutrient absorption. Several essential minerals, including iron, calcium, magnesium, and vitamin B12, require an acidic environment to be properly absorbed in the small intestine. When stomach acid production is chronically suppressed, the bioavailability of these nutrients decreases, potentially leading to deficiencies. For example, iron exists in different forms, and stomach acid helps convert it into a form that the body can readily absorb. Similarly, calcium absorption is enhanced by an acidic gastric environment. The longer PPIs are used, the greater the potential for these absorption issues to develop.
Concerns Over Overuse and Over-the-Counter Availability
Omeprazole has been available for over three decades and remains a frequently prescribed medication. However, its widespread use, often extending for months or even years without consistent medical supervision, is a growing concern. Andréa Santana de Brito, a researcher at UNIFESP, highlights that the problem lies not in the drug itself, but in its “trivialized use” for mild symptoms like occasional heartburn. “It isn’t a question of demonizing the drug, which is effective for various gastric conditions. The problem is its trivialized use, even for mild symptoms such as heartburn, and for prolonged periods of months and even years. Its adverse effects shouldn’t be overlooked,” she explains.
This concern is amplified by recent regulatory changes. The Brazilian Health Regulatory Agency (ANVISA) authorized the over-the-counter sale of 20mg omeprazole in November 2025. ANVISA official website While ANVISA maintains that this move aims to promote “rational use” by limiting treatment to a maximum of 14 days and encouraging patients to seek medical evaluation for persistent symptoms, researchers like de Brito worry that easier access will encourage self-medication and prolonged, unsupervised use. Packages containing more than a 14-day supply will still require a prescription, but the initial availability of a short course could lead to extended self-treatment.
Impact on Other PPIs and Potential Mitigation Strategies
The research conducted at UNIFESP and FMABC focused on omeprazole, but the researchers emphasize that other PPIs, including pantoprazole and esomeprazole, function through a similar mechanism and are likely to have comparable effects on mineral absorption. In fact, some newer PPIs may have an even more pronounced impact due to their longer duration of action. Brito notes that these molecules can take longer to allow for the regeneration of proton pumps, potentially intensifying side effects.
While the link between PPIs and reduced nutrient absorption is established, this research expands our understanding by examining a broader range of minerals, including magnesium and zinc. Nogueira emphasizes the importance of rational PPI use and, in some cases, assessing the need for supplementation. However, he stresses that medical supervision is essential to evaluate each case individually and determine the appropriate course of action. Regular monitoring of nutrient levels, particularly iron, vitamin B12, and magnesium, may be advisable for individuals on long-term PPI therapy.
Key Takeaways
- Prolonged PPI use can disrupt nutrient absorption: Specifically impacting iron, calcium, magnesium, zinc, and vitamin B12.
- Mineral imbalances pose health risks: Leading to potential anemia, osteoporosis, and impaired immune function.
- Over-the-counter access raises concerns: Increased availability may encourage self-medication and prolonged use.
- Medical supervision is crucial: Regular monitoring and potential supplementation should be discussed with a healthcare provider.
The increasing awareness of these potential risks is prompting a more cautious approach to PPI prescribing. Healthcare professionals are encouraged to carefully evaluate the necessity of long-term PPI therapy, explore alternative treatment options where appropriate, and educate patients about the potential consequences of prolonged use. The future of acid reflux management may involve a more personalized approach, balancing the benefits of symptom relief with the need to preserve optimal nutrient status. Further research is ongoing to fully elucidate the long-term effects of PPIs and to develop strategies for mitigating potential risks.
The Brazilian regulatory agency, ANVISA, will continue to monitor the impact of the over-the-counter availability of omeprazole following its implementation in November 2025. Ongoing surveillance and data analysis will be crucial to assess whether the agency’s measures to promote responsible use are effective. Patients experiencing persistent heartburn or acid reflux should consult with their healthcare provider to determine the most appropriate treatment plan.
Do you have experience with long-term PPI use? Share your thoughts and questions in the comments below. Please share this article with anyone you know who may be affected by these findings.
Worth a look